Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Assam govt to tweak...

    Assam govt to tweak investment policies to attract pharma industry

    Written by Ruby Khatun Khatun Published On 2018-02-05T10:45:47+05:30  |  Updated On 5 Feb 2018 10:45 AM IST
    Assam govt to tweak investment policies to attract pharma industry

    Guwahati: Assam government on Sunday said it is ready to tweak its investment policies to attract the pharmaceutical sector for setting up units in the state.


    As there is no specific pharma policy in Assam, the government is ready to tweak the existing norms to suit the industry players of the healthcare segment to come and invest in the state, state Finance Minister Himanta Biswa Sarma said at the ongoing Global Investment Summit here.


    "We have a general investment policy. But some of your requirements may be different. The government of Assam is willing to customise the parameters for your requirements," the minister said.


    "We will facilitate and go whatever way to help you invest in Assam.


    The government and political class here is helpful to you. We want investment. So we will go an extra mile to have you in our state," he said.


    Sarma, who is also the Health Minister, said the government wants to transform the state and create jobs for the youths.


    Health and Family Welfare Department Commissioner Samir Kumar Sinha said that Assam saw an investment of $142 million (over Rs 900 crore) in the healthcare segment with the setting up of nine pharma units.


    "The Assam government has been giving top priority to healthcare segment. The Budget allocation for the health and family welfare of the state in 2017-18 jumped by 17 percent from 2016-17. This was one of the highest," he added.


    On this occasion, a Memorandum of Understanding was signed between Indian Institute of Technology-Guwahati and Kalam Institute of Health Technology to source innovation from the Assam-based centre and auction them to the industry.

    AssamGlobal Investment SummitgovernmentHealth and Family WelfareHealthcareHimanta Biswa Sarmainvestment policiesMemorandum of UnderstandingPharma Industrypharma policypharmaceutical sectorSamir Kumar Sinhastate Finance Ministertweak
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok